Allyl acetic acid

Allyl acetic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 381 references associated with Allyl acetic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Allyl acetic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Allyl acetic acid

MeSH term MeSH ID Detail
Hyperglycemia D006943 21 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Hepatic Encephalopathy D006501 9 associated lipids
Brain Diseases D001927 27 associated lipids
Starvation D013217 47 associated lipids
Reye Syndrome D012202 14 associated lipids
Total 6

PubChem Associated disorders and diseases

NCBI Entrez Crosslinks

All references with Allyl acetic acid

Download all related citations
Per page 10 20 50 100 | Total 125
Authors Title Published Journal PubMed Link
Hu X et al. Dual-pH/Magnetic-Field-Controlled Drug Delivery Systems Based on Fe O @SiO -Incorporated Salecan Graft Copolymer Composite Hydrogels. 2017 ChemMedChem pmid:28857472
Abdin A and Sarhan N Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity. 2014 Can. J. Physiol. Pharmacol. pmid:25162205
Chernikov AV et al. [Effect of the energy metabolism regulator Yantar-Antitox on the system of energy production in rat liver during experimental pathology of beta-oxidation]. 2012 Eksp Klin Farmakol pmid:22834125
Todd JD et al. The Ruegeria pomeroyi acuI gene has a role in DMSP catabolism and resembles yhdH of E. coli and other bacteria in conferring resistance to acrylate. 2012 PLoS ONE pmid:22563425
Patgiri A et al. An orthosteric inhibitor of the Ras-Sos interaction. 2011 Nat. Chem. Biol. pmid:21765406
Bai X et al. Bile acid-based cage compounds with lipophilic outer shells and inner cavities. 2011 Org. Lett. pmid:21591628
Palkovits R Pentenoic acid pathways for cellulosic biofuels. 2010 Angew. Chem. Int. Ed. Engl. pmid:20480484
Wiessler M et al. Extension of the PNA world by functionalized PNA monomers eligible candidates for inverse Diels Alder Click Chemistry. 2010 Int J Med Sci pmid:20617125
Höfer P et al. Production of functionalized polyhydroxyalkanoates by genetically modified Methylobacterium extorquens strains. 2010 Microb. Cell Fact. pmid:20846434
Whitehead DC et al. An organocatalytic asymmetric chlorolactonization. 2010 J. Am. Chem. Soc. pmid:20170118
Luo T and Schreiber SL Gold(I)-catalyzed coupling reactions for the synthesis of diverse small molecules using the build/couple/pair strategy. 2009 J. Am. Chem. Soc. pmid:19331418
Nagai G et al. Formulations of valproate alter valproate metabolism: a single oral dose kinetic study. 2009 Ther Drug Monit pmid:19704403
Xue P et al. Total synthesis of (-)-talaumidin and (-)-galbelgin. 2009 J Asian Nat Prod Res pmid:19408154
Hall DR et al. (S)-2-acetoxy-5-undecanone, female sex pheromone of the raspberry cane midge, Resseliella theobaldi (Barnes). 2009 J. Chem. Ecol. pmid:19169750
Gurvitz A Caenorhabditis elegans F09E10.3 encodes a putative 3-oxoacyl-thioester reductase of mitochondrial type 2 fatty acid synthase FASII that is functional in yeast. 2009 J. Biomed. Biotechnol. pmid:19746209
Peng X et al. Bimetallic dendrimer-encapsulated nanoparticles as catalysts: a review of the research advances. 2008 Chem Soc Rev pmid:18648686
Hermann M et al. Alternative pig liver esterase (APLE) - cloning, identification and functional expression in Pichia pastoris of a versatile new biocatalyst. 2008 J. Biotechnol. pmid:18078679
VengerovskiÄ­ AI and Khazanov VA [Effects of silymarin and its combination with succinic acid on brain bioenergetics in rats with experimental inhibition of beta-oxidation of fatty acids]. 2007 Mar-Apr Eksp Klin Farmakol pmid:17523453
Boivin J and Nguyen VT Part 3. Triethylborane-air: a suitable initiator for intermolecular radical additions of S-2-oxoalkyl-thionocarbonates (S-xanthates) to olefins. 2007 Beilstein J Org Chem pmid:18078507
Allais F et al. Part 2. Mechanistic aspects of the reduction of S-alkyl-thionocarbonates in the presence of triethylborane and air. 2007 Beilstein J Org Chem pmid:18076755
Fraccascia P et al. Presence of thiamine pyrophosphate in mammalian peroxisomes. 2007 BMC Biochem. pmid:17596263
Khazanov VA and Vengerovsky AI Effect of silimarin, succinic acid, and their combination on bioenergetics of the brain in experimental encephalopathy. 2007 Bull. Exp. Biol. Med. pmid:18856206
Ramm W et al. Diglucosyl-glycerolipids from the marine sponge-associated Bacillus pumilus strain AAS3: their production, enzymatic modification and properties. 2004 Appl. Microbiol. Biotechnol. pmid:14593508
de Longueville F et al. Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. 2003 Toxicol. Sci. pmid:12883083
Lee HJ et al. Accumulation of polyhydroxyalkanoic acid containing large amounts of unsaturated monomers in Pseudomonas fluorescens BM07 utilizing saccharides and its inhibition by 2-bromooctanoic acid. 2001 Appl. Environ. Microbiol. pmid:11679314
VengerovskiÄ­ AI et al. [Therapeutic effect of hepatoprotectors in experimental Reye syndrome]. 2000 Sep-Oct Eksp Klin Farmakol pmid:11109534
Palmeira CM et al. Induction of the mitochondrial permeability transition in vitro by short-chain carboxylic acids. 2000 Biochem. Biophys. Res. Commun. pmid:10833431
Saratikov AS et al. [Effects of phospholipid hepatoprotective agents in experimental Reye syndrome]. 2000 Biull Eksp Biol Med pmid:10776581
Saratikov AS et al. Experimental models of Reye's syndrome. 2000 Bull. Exp. Biol. Med. pmid:10977933
Laurent A et al. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. 2000 Toxicol. Lett. pmid:10713486
Miura K et al. No participation of adenosine A1 receptor in acute nephrotoxicity by 4-pentenoic acid administration in dogs. 1999 Jpn. J. Pharmacol. pmid:10461767
Varela A et al. Effects of pentanoate, 4-pentenoate, 3-hydroxybutyrate and insulin on the tissue-levels of long-chain acyl CoA and acylcarnitine in the oxygenated and hypoxic rat atria. 1999 Arch. Physiol. Biochem. pmid:10455555
Tang W et al. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. 1995 Jul-Aug Chem. Res. Toxicol. pmid:7548749
Rossi R et al. Hyperpolarization of the cell membrane of mouse hepatocytes by fatty acid oxidation. 1995 Physiol. Behav. pmid:7753889
Hurst JS et al. The incorporation and release of 12(S)-hydroxyeicosatetraenoic acid and its major metabolite, 8(S)-hydroxyhexadecatrienoic acid, from rabbit corneal lipids. 1994 Exp. Eye Res. pmid:7835402
Kassahun K and Abbott F In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid. 1993 Nov-Dec Drug Metab. Dispos. pmid:7905390
Boulanger Y et al. Heterogeneous metabolism and toxicity of 4-pentenoate along the dog nephron. 1993 Jul-Aug Ren. Physiol. Biochem. pmid:7689241
Gougoux A et al. Metabolic effects of 4-pentenoate on isolated dog kidney tubules. 1992 Kidney Int. pmid:1405336
Pouliot JF et al. Brush border membrane proteins in experimental Fanconi's syndrome induced by 4-pentenoate and maleate. 1992 Can. J. Physiol. Pharmacol. pmid:1493592
Page WJ et al. Formation of poly(hydroxybutyrate-co-hydroxyvalerate) by Azotobacter vinelandii UWD. 1992 Appl. Environ. Microbiol. pmid:1444399
Boulanger Y et al. 13C and 1H NMR study of the metabolic degradation of 4-pentenoate in different dog nephron segments. 1992 Magn Reson Med pmid:1435217
Beverly JL and Martin RJ Influence of fatty acid oxidation in lateral hypothalamus on food intake and body composition. 1991 Am. J. Physiol. pmid:1877693
Taylor DR and Williams GT Differentiation and limited proliferation of isolated Leishmania mexicana amastigotes at 27 degrees C. 1991 Acta Trop. pmid:1685870
Hidaka T et al. Prevention of 4-pentenoic acid-induced liver injury in rats by 16,16-dimethyl PGE2. 1991 Exp. Mol. Pathol. pmid:1936211
Garcia-Salguero L et al. Metabolic adaptation of renal carbohydrate metabolism. IV. The use of site-specific liver gluconeogenesis inhibitors to ascertain the role of renal gluconeogenesis. 1991 Arch Int Physiol Biochim Biophys pmid:1717058
Yuge K Carnitine metabolism in rats with 4-pentenoic acid induced fatty liver. 1990 Acta Paediatr Jpn pmid:2288228
Sakaida N et al. Microvesicular fatty liver in rats with resembling Reye's syndrome induced by 4-pentenoic acid. 1990 Acta Pathol. Jpn. pmid:2260472
Sugimoto T et al. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats. 1990 Brain Dev. pmid:2240462
Porubek DJ et al. The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes. 1989 Mar-Apr Drug Metab. Dispos. pmid:2565201
Gougoux A et al. Experimental Fanconi's syndrome resulting from 4-pentenoate infusion in the dog. 1989 Am. J. Physiol. pmid:2603963
Katafuchi Y et al. Effects of drugs and fatty acids related to Reye syndrome on brain water content in rats. 1989 Acta Paediatr Jpn pmid:2516690
Gordon JA et al. Identification of the major metabolite of 12-HETE produced by renal tubular epithelial cells. 1989 J. Lipid Res. pmid:2760546
Hart MA et al. Alterations in plasma amino acids and hepatic enzymes in the 4-pentenoic acid model of Reye's syndrome. 1989 Biochem. Pharmacol. pmid:2730684
Michaletz PA et al. Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. 1989 Hepatology pmid:2807162
Caspers ML and Grammas P Effect of fatty acids on [3H]ouabain binding to cerebromicrovascular (Na+ + K+)-ATPase. 1988 J. Neurochem. pmid:2831300
Kitchin KT and Brown JL Allylisopropylacetamide induces rat hepatic ornithine decarboxylase. 1987 Fall-Winter J. Biochem. Toxicol. pmid:3508473
Nakagawa M et al. Effect of clofibrate on lipid peroxidation in rats treated with aspirin and 4-pentenoic acid. 1987 J. Biochem. pmid:3571211
el-Aleem SA and Schulz H Evaluation of inhibitors of fatty acid oxidation in rat myocytes. 1987 Biochem. Pharmacol. pmid:3689454
Pryor HJ et al. Evidence that the flux control coefficient of the respiratory chain is high during gluconeogenesis from lactate in hepatocytes from starved rats. Implications for the hormonal control of gluconeogenesis and action of hypoglycaemic agents. 1987 Biochem. J. pmid:3426547
Rabier D et al. Effects of organic acids on the synthesis of citrulline by intact rat liver mitochondria. 1986 Biochimie pmid:2873843
Quinlan PT and Halestrap AP The mechanism of the hormonal activation of respiration in isolated hepatocytes and its importance in the regulation of gluconeogenesis. 1986 Biochem. J. pmid:3024626
Deshmukh DR Animal models of Reye's syndrome. 1985 Jan-Feb Rev. Infect. Dis. pmid:3885365
Pausch J et al. Hepatic carbamoyl phosphate metabolism. Role of cytosolic and mitochondrial carbamoyl phosphate in de novo pyrimidine synthesis. 1985 Eur. J. Biochem. pmid:4018077
Duée PH et al. Separate effects of fatty acid oxidation and glucagon on gluconeogenesis in isolated hepatocytes from newborn pigs. 1985 Biol. Neonate pmid:3978159
Zhong J et al. Inhibition of carnitine acetyltransferase by metabolites of 4-pentenoic acid. 1985 Arch. Biochem. Biophys. pmid:4026294
Van Hoof F et al. Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study. 1985 Biochem. J. pmid:4038275
Sherratt HS Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates. 1985 Biochem. Soc. Trans. pmid:2866127
Pausch J et al. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver. 1985 Adv. Enzyme Regul. pmid:3835821
Kesterson JW et al. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. 1984 Nov-Dec Hepatology pmid:6437960
Sherratt HS and Veitch RK Animal models for dicarboxylic aciduria. 1984 J. Inherit. Metab. Dis. pmid:6434846
Coudé FX et al. Potentiation by ammonia of the metabolic effects of pent-4-enoate in isolated rat hepatocytes. 1984 Biochem. J. pmid:6508762
Coude FX and Grimber G Inhibition of urea synthesis by pent-4-enoic acid: potentiation by ammonia. 1984 Biochem. Biophys. Res. Commun. pmid:6696766
Thayer WS Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome. 1984 Biochem. Pharmacol. pmid:6712730
Schulz H Metabolism of 4-pentenoic acid and inhibition of thiolase by metabolites of 4-pentenoic acid. 1983 Biochemistry pmid:6133549
Coombs GH et al. Leishmania mexicana: drug sensitivities of promastigotes and transforming amastigotes. 1983 J. Antimicrob. Chemother. pmid:6833171
Hiltunen JK and Davis EJ Metabolism of pent-4-enoate in rat heart. Reduction of the double bond. 1981 Biochem. J. pmid:7305999
Schulz H and Fong JC 4-Pentenoic acid. 1981 Meth. Enzymol. pmid:7311857
Yasuda M et al. Effects of 4-pentenoic acid and furosemide on renal functions and renal uptake of individual free fatty acids. 1980 Pflugers Arch. pmid:7190268
Borrebaek B et al. In vivo induction of 4-enoyl-CoA reductase by clofibrate in liver mitochondria and its effect on pent-4-enoate metabolism. 1980 Biochem. Biophys. Res. Commun. pmid:7396904
Santaniello E and Manzocchi A A simple and convenient preparation of succinic semialdehyde. 1980 Anal. Biochem. pmid:7457857
Borrebaek B et al. Increased 4-enoyl-CoA reductase activity in liver mitochondria of rats fed high-fed diets and its effect on fatty acid oxidation and the inhibitory action of pent-4-enoate. 1980 FEBS Lett. pmid:7461116
Hiltunen JK et al. Isolated rat heart mitochondria are able to metabolize pent-4-enoate to tricarboxylic acid-cycle intermediates. 1980 Biochem. J. pmid:7470030
Billington D Mechanism of the hypoglycaemia caused by hypoglycin and pent-4-enoate. 1979 Biochem. Soc. Trans. pmid:437248
Van Hoof F et al. Protection of rats against hypoglycin and pent-4-enoate toxicity by pretreatment with clofibrate [proceedings]. 1979 Biochem. Soc. Trans. pmid:437267
Mannaerts GP et al. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. 1979 J. Biol. Chem. pmid:438207
Ferré P et al. Interactions in vivo between oxidation of non-esterified fatty acids and gluconeogenesis in the newborn rat. 1979 Biochem. J. pmid:508300
Aoyagi K et al. Inhibition of urea synthesis by pent-4-enoate associated with decrease in N-acetyl-L-glutamate concentration in isolated rat hepatocytes. 1979 Biochim. Biophys. Acta pmid:508801
Hiltunen JK et al. Effects of pent-4-enoate on cellular redox state, glycolysis and fatty acid oxidation in isolated perfused rat heart. 1978 Biochem. J. pmid:205208
Osmudsen H Effects of pent-4-enoate on flux through acyl-CoA dehydrogenases of beta-oxidation in intact rat liver mitochondria. 1978 FEBS Lett. pmid:648633
Lenzen S Effects of alpha-ketocarboxylic acids and 4-pentenoic acid on insulin secretion from the perfused rat pancreas. 1978 Biochem. Pharmacol. pmid:697934
Billington D et al. Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vitro studies. 1978 Biochem. Pharmacol. pmid:736981
Billington D et al. Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vivo studies. 1978 Biochem. Pharmacol. pmid:736982
Fong JC and Schulz H On the rate-determining step of fatty acid oxidation in heart. Inhibition of fatty acid oxidation by 4-pentenoic acid. 1978 J. Biol. Chem. pmid:29043
Pégorier JP et al. The effects of inhibition of fatty acid oxidation in suckling newborn rats. 1977 Biochem. J. pmid:597245
Glasgow AM Effect of 4-pentenoate on rat liver ornithine transcarbamylase. 1977 Pediatr. Res. pmid:846784
Yeh YY et al. Relative utilization of fatty acids for synthesis of ketone bodies and complex lipids in the liver of developing rats. 1977 Lipids pmid:857111
Yeoh HH et al. Effects of 4-pentenoic acid on renal phosphate and calcium excretion in the dog. 1976 Am. J. Physiol. pmid:961862
Stanley H et al. On the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent-4-enoic acid. A way out of the present confusion. 1976 Biochem. Pharmacol. pmid:938577
Osmundsen H and Sherratt HS The effects of pent-4-enoate and methylenecyclopropylacetate on some enzymes of beta-oxidation in extracts of liver mitochondria. 1975 Biochem. Soc. Trans. pmid:1169177
Fujita T and Yasuda M Effect of 4-pentenoic acid on lipids in plasma and liver of rats. 1975 Jpn. J. Pharmacol. pmid:1152311